247 related articles for article (PubMed ID: 15057603)
1. Ultrastructural study of benign, low-malignant potential (LMP), and malignant ovarian tumors.
Ishioka S; Sagae S; Ito E; Kudo R
Med Electron Microsc; 2004 Mar; 37(1):37-44. PubMed ID: 15057603
[TBL] [Abstract][Full Text] [Related]
2. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
3. The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinoma.
Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
Anticancer Res; 2003; 23(6C):4657-62. PubMed ID: 14981910
[TBL] [Abstract][Full Text] [Related]
4. Common epithelial tumors of the ovary: proliferating and of low malignant potential.
Ulbright TM; Roth LM
Semin Diagn Pathol; 1985 Feb; 2(1):2-15. PubMed ID: 2832916
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomics of ovarian epithelial tumors.
An HJ; Kim DS; Park YK; Kim SK; Choi YP; Kang S; Ding B; Cho NH
J Proteome Res; 2006 May; 5(5):1082-90. PubMed ID: 16674097
[TBL] [Abstract][Full Text] [Related]
6. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?
Fukumoto M; Nakayama K
Pathol Int; 2006 May; 56(5):233-9. PubMed ID: 16669871
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
8. Proliferative endometrioid tumors and endometrioid tumors of low malignant potential of the ovary.
Norris HJ
Int J Gynecol Pathol; 1993 Apr; 12(2):134-40. PubMed ID: 8463037
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ
Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054
[TBL] [Abstract][Full Text] [Related]
10. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
12. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
Kempson RL; Hendrickson MR
Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
14. Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients.
Aggarwal A; Lucco KL; Lacy J; Kives S; Gerstle JT; Allen L
J Pediatr Surg; 2009 Oct; 44(10):2023-7. PubMed ID: 19853767
[TBL] [Abstract][Full Text] [Related]
15. No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms.
Shih YC; Kerr J; Hurst TG; Khoo SK; Ward BG; Chenevix-Trench G
Gynecol Oncol; 1998 Jun; 69(3):210-3. PubMed ID: 9648589
[TBL] [Abstract][Full Text] [Related]
16. Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential.
Meinhold-Heerlein I; Bauerschlag D; Hilpert F; Dimitrov P; Sapinoso LM; Orlowska-Volk M; Bauknecht T; Park TW; Jonat W; Jacobsen A; Sehouli J; Luttges J; Krajewski M; Krajewski S; Reed JC; Arnold N; Hampton GM
Oncogene; 2005 Feb; 24(6):1053-65. PubMed ID: 15558012
[TBL] [Abstract][Full Text] [Related]
17. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
18. Multiple primary neoplasms. Ovarian carcinoid tumor, mucinous cystadenoma of low malignant potential tumor of left ovary, and adenocarcinoma of the colon.
Capaldo GR; Kunschner AJ; Amin RM
Arch Pathol Lab Med; 1996 Apr; 120(4):393-6. PubMed ID: 8619754
[TBL] [Abstract][Full Text] [Related]
19. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
20. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL
Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]